Revenue Breakdown
Composition ()
No data
Revenue Streams
Tvardi Therapeutics Inc (TVRD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Other revenue , accounting for 51.5% of total sales, equivalent to $1.32M. Other significant revenue streams include Collaborative revenue and Clinical compound revenue. Understanding this composition is critical for investors evaluating how TVRD navigates market cycles within the Biotechnology & Medical Research industry.
Profitability & Margins
Evaluating the bottom line, Tvardi Therapeutics Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -455.79%, provide a clear picture of how effectively TVRD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, TVRD competes directly with industry leaders such as JSPR and INMB. With a market capitalization of $36.31M, it holds a significant position in the sector. When comparing efficiency, TVRD's gross margin of N/A stands against JSPR's N/A and INMB's 100.00%. Such benchmarking helps identify whether Tvardi Therapeutics Inc is trading at a premium or discount relative to its financial performance.
